THE ROYAL MARSDEN CANCER CHARITY
Financial health, per its FY2025 accounts
The accounts state that total funds increased to £130.2 million, with free reserves of £36.3 million significantly exceeding the stated policy target of £10 million. The charity generated £34 million in income and made £26.8 million in grants, resulting in a strong financial position with no material uncertainties reported regarding its ability to continue as a going concern.
What the accounts disclose
“The Managing Director’s basic salary in 2024/25 was £149,102 (2023/24: £143,367).” — page 31
“Trustees maintained the free reserves policy target level at £10 million with a minimum level of £5 million, equivalent to at least six months of direct fundraising expenditure.”
“Grant and funding awarded to The Royal Marsden during the year was £23 million (2023/24: £19.5 million). Grants payable owed to The Royal Marsden at 31 March 2025 totalled £40.8 million (31 March 2024: £33.6 million). The Charity has provided an interest-free loan of £226,000 (2023/24: £226,000) to The Royal Marsden to offer support to staff for season tickets and bicycle purchases.”
“The Royal Marsden NHS Foundation Trust also provides a number of services to the Charity, which are recharged under a contractual service level agreement. The total amount payable to The Royal Marsden for its staff under the service level agreement for the year was £218,000 (2023/24: £363,000), with an additional £155,000 (2023/24: £24,000) in relation to other ancillary services.”
“Grant and funding awarded to The Royal Marsden during the year was £23 million (2023/24: £19.5 million). Grants payable owed to The Royal Marsden at 31 March 2025 totalled £40.8 million (31 March 2024: £33.6 million). The Charity has provided an interest-free loan of £226,000 (2023/24: £226,000) to The Royal Marsden to offer support to staff for season tickets and bicycle purchases.”
“The Royal Marsden NHS Foundation Trust also provides a number of services to the Charity, which are recharged under a contractual service level agreement. The total amount payable to The Royal Marsden for its staff under the service level agreement for the year was £218,000 (2023/24: £363,000), with an additional £155,000 (2023/24: £24,000) in relation to other ancillary services.”
“Grant and funding awarded to The Royal Marsden during the year was £23 million (2023/24: £19.5 million). Grants payable owed to The Royal Marsden at 31 March 2025 totalled £40.8 million (31 March 2024: £33.6 million). The Charity has provided an interest-free loan of £226,000 (2023/24: £226,000) to The Royal Marsden to offer support to staff for season tickets and bicycle purchases.”
“The Royal Marsden NHS Foundation Trust also provides a number of services to the Charity, which are recharged under a contractual service level agreement. The total amount payable to The Royal Marsden for its staff under the service level agreement for the year was £218,000 (2023/24: £363,000), with an additional £155,000 (2023/24: £24,000) in relation to other ancillary services.”
“The Group consists of The Royal Marsden Cancer Charity and Royal Marsden Cancer Campaign Trading Company Limited.”
Corporate structure
- Registered company of the charity Companies House 04615761
- Trading subsidiary: ROYAL MARSDEN CANCER CAMPAIGN TRADING COMPANY LIMITED Companies House 04722285
Leadership, per the charity’s website
- Sir Douglas Flint CBE — Chairman
- Antonia Dalmahoy — Managing Director
Structured financials (annual return, FY ending 31/03/2025)
Register events
- Received assets from another charity (21/10/2025)
- Received assets from another charity (07/06/2024)
- Received assets from another charity (29/08/2023)
- Received assets from another charity (06/07/2023)
- Received assets from another charity (30/03/2023)
- Received assets from another charity (09/05/2022)
Trustees
- Sir DOUGLAS JARDINE FLINT CBEchair
- Andrew Fisher OBE
- Anuj Ranjan
- Baroness Olivia Caroline Bloomfield
- Dame Anya Hindmarch DBE
- Dame CAROLINE PALMER
- Professor David Cunningham
- ROGER GRAY
- Russell Chambers
- Sir Terry Leahy
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £34.0m | £36.5m |
| 31/03/2024 | £35.9m | £28.2m |
| 31/03/2023 | £34.4m | £21.7m |
| 31/03/2022 | £31.2m | £43.2m |
| 31/03/2021 | £32.9m | £48.5m |
Common questions
Is THE ROYAL MARSDEN CANCER CHARITY financially healthy?
The accounts state that total funds increased to £130.2 million, with free reserves of £36.3 million significantly exceeding the stated policy target of £10 million. The charity generated £34 million in income and made £26.8 million in grants, resulting in a strong financial position with no material uncertainties reported regarding its ability to continue as a going concern. Its FY2025 accounts were audited by Buzzacott Audit LLP.
What does the highest-paid employee of THE ROYAL MARSDEN CANCER CHARITY earn?
Per its FY2025 accounts, the highest-paid employee was in the £140,001 - £150,000 band.
Who funds THE ROYAL MARSDEN CANCER CHARITY?
Funders whose own accounts filings name THE ROYAL MARSDEN CANCER CHARITY as a grant recipient include DENISE COATES FOUNDATION, THE DORFMAN FOUNDATION, LADY GARDEN FOUNDATION, THE THOMPSON FAMILY CHARITABLE TRUST, KUSUMA TRUST UK.
Known funders
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| COUNTY AIR AMBULANCE TRUST | 1 | £354k |
| PARKINSON'S DISEASE SOCIETY OF THE UNITED KINGDOM | 1 | £169k |
| THE BRIDGE RENEWAL TRUST | 1 | £131k |
| ENFIELD LIONS CLUB (CIO) | 1 | £50k |
| THE DANSON FOUNDATION | 1 | £20k |
| THE STELLA AND ALEXANDER MARGULIES CHARITABLE TRUST | 1 | £18k |
| THE ELIZABETH FRANKLAND MOORE AND STAR FOUNDATION | 1 | £16k |
| THE VICTORIA FOUNDATION | 1 | £9k |